Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For DBG.PA
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth n.A.
Leverage & Liquidity Balanced
50%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q4 Q2 Δ in %
Current Ratio -6.71 0.97 1.04
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 13.17 5.46 4.82
Naive Interpretation member
2 Per Share
Metric Q4 Q2 Δ in %
Book Value 0.41 6.24 6.21
Cash -13.68 0.88 1.02
Capex -30.76 -0.64 -0.49
Free Cash Flow 25.04 0.35 0.28
Revenue -3.72 10.87 11.29
Naive Interpretation member
3 Profitability
Metric Q4 Q2 Δ in %
Gross Margin -18.67 0.04 0.05
Operating Margin -19.61 0.04 0.05
ROA -52.07 0.01 0.03
ROE -52.17 0.03 0.07
ROIC -39.02 0.02 0.04
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of DBG.PA is permitted for members.
5 Growth
The "Growth Entry" for the Focus of DBG.PA is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of DBG.PA is permitted for members.